Daniel W. Lin, MD

Dr. Lin received an undergraduate degree from Stanford University and a medical degree from Vanderbilt University. He then did a urology residency at UW Medicine and a clinical urologic oncology fellowship at Memorial Sloan-Kettering Cancer Center, followed by an American Foundation for Urologic Disease Physician Scholar Award at Fred Hutchinson Cancer Research Center.

Dr. Lin has co-authored more than 100 papers, chapters and editorials and is associate editor of three journals. He serves on various national committees, including the National Comprehensive Cancer Network Guideline Panel for Renal and Testis Tumors, the Society of Urologic Oncology Executive Board, and the AUA Guideline Committees for Advanced Prostate Cancer and Renal Mass Follow-up.

Dr. Lin’s major basic/translational research interests are in prostate chemoprevention and carcinogenesis, and his major clinical research efforts are in active surveillance of prostate cancer and management of high-risk prostate cancer. This work is funded by multiple peer-reviewed awards from the National Cancer Institute, the Department of Defense and the Department of Veterans’ Affairs (VA)